Whole sample (n = 90) | Treatment seeking group (n = 41) | Non-treatment seeking group (n = 49) | ||||||
---|---|---|---|---|---|---|---|---|
Mean (SD) | Mean (SD) | Range | Mean (SD) | Range | t | p-value | ||
Age (years) | 38.9 (10.6) | 36.3 (11.3) | 22-74 | 41.2 (9.5) | 25-60 | 2.216 | 0.029* | |
Education (years) | 14.8 (2.4)22 | 14.8 (2.3) | 9-19 | 14.8 (2.6) | 10-23 | -0.072 | 0.943 | |
AAS debut age | 22.6 (7.8) | 21.6 (7.8) | 15-55 | 23.5 (7.9) | 16-50 | 1.161 | 0.249 | |
Accumulated AAS use (years) | 11.9 (8.5) | 11.6 (8.7) | 1.5-29 | 12.2 (8.4) | 1-29 | 0.338 | 0.736 | |
n | % | n | % | n | % | χ2 | p-value | |
AAS dependence (SCID, 5 missing) | 52 (n = 85) | 61.2 | 24 (n = 40) | 60.0 | 28 (n = 45) | 62.2 | 0.044 | 0.834 |
Current AAS use | 59 | 65.6 | 25 | 61.0 | 34 | 69.4 | 0.7 | 0.403 |
Current employment | 70 | 77.7 | 31 | 75.6 | 39 | 79.6 | 0.205 | 0.651 |
Student | 15 | 16.7 | 6 | 14.6 | 9 | 18.4 | 0.224 | 0.636 |
Children | 57 | 63.3 | 26 | 63.4 | 31 | 63.3 | 0.002 | 0.988 |
AU/week (mean, SD, range, t) | 2.2 (2.9) | 0-12 | 2.4 (3.3) | 0-12 | 1.9 (2.6) | 0-10 | 0.797 | 0.428 |
AUDIT ≥ 8 | 17 | 19.5 | 6 | 15.4 | 11 | 22.9 | 0.776 | 0.378 |
Regular illicit substance use | 26 | 28.9 | 10 | 24.4 | 16 | 32.7 | 0.742 | 0.389 |
DUDIT ≥ 6 | 12 | 13.3 | 7 | 17.1 | 5 | 10.2 | 0.912 | 0.340 |
Psychopharmacological treatment, life-time | 36 | 40 | 19 | 46.3 | 17 | 34.7 | 1.262 | 0.261 |
Psychopharmacological treatment, current | 13 | 14.4 | 8 | 19.2 | 5 | 10.2 | 1.565 | 0.211 |
Antidepressants, life-time | 21 | 23.3 | 13 | 31.7 | 8 | 16.3 | 3.195 | 0.074 |
Antidepressants, current | 5 | 5.5 | 2 | 4.9 | 3 | 6.1 | 0.066 | 1.000 |
Anxiolytics, life-time | 23 | 25.5 | 12 | 29.3 | 11 | 22.4 | 0.546 | 0.460 |
Anxiolytics, current | 9 | 10 | 8 | 19.5 | 1 | 2.0 | 7.571 | 0.010* |
Antipsychotics, life-time | 5 | 5.5 | 3 | 7.3 | 2 | 4.1 | 0.452 | 0.656 |
Antipsychotics, current | 4 | 4.4 | 2 | 4.9 | 2 | 4.1 | 0.033 | 1.000 |